BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2004
View Archived Issues
Caspases involved in immune thrombocytopenia
Read More
A triple TCR peptide vaccine shows promise in patients with multiple sclerosis
Read More
Novel CDK inhibitors from BMS show in vivo anticancer activity
Read More
Prous Science announces publication of a comprehensive review on insomnia
Read More
Shipment of Xifaxan under way
Read More
Conditional expansion of Sepracor and Aventis eszopiclone agreement
Read More
Nuvelo closes phase II alfimeprase study early
Read More
Spheramine granted fast track status for advanced Parkinson's disease
Read More
Potent glycogen synthase kinase-3beta inhibitors effective in vivo
Read More
Anti-CCR5 monoclonal antibody PRO-140 controls HIV-1 replication in vivo
Read More
CCR5 antagonist with potent anti-HIV activity in vitro
Read More
Genistein induces apoptosis in HIV-infected cells in vitro
Read More
Combination treatment with olive oil extract effective against HIV
Read More
Amarin to acquire Laxdale
Read More
Rotigotine reduces RLS symptoms in phase IIb trial
Read More
Bayer extends support for study in prophylactic treatment of hemophilia A
Read More
Cellegy and Strakan enter European commercialization agreement for Tostrex
Read More
EnVivo and MethylGene to develop isotypic HDAC inhibitors
Read More
PTC-124 enters phase I for cystic fibrosis and Duchenne muscular dystrophy
Read More
Initiation of final pivotal phase III study of doripenem for VAP
Read More
CLIA waiver for Uni-Gold Recombigen HIV test
Read More
Posaconazole NDA accepted for review
Read More
Phenomix and Genentech establish collaboration for immune disorders
Read More
Inhibitors of kinases claimed by Schering AG
Read More
Indolyl derivatives claimed by Roche
Read More
Silicon compounds for the treatment of cancer reported by Amedis
Read More
Active Biotech describes CD80 antagonists
Read More
Selective COX-2 inhibitors described by researchers at CJ Corporation
Read More